Table I.
Clinicopathological data of the patients who provided UC regenerative specimens.
| Number of cases | Age (years) (mean ± s.d.) | Gender (M:F) | Number of samples | Number of samples classified by Matts score | Duration from the onset of UC (years mean ± s.d.) | |
|---|---|---|---|---|---|---|
| Normal control | 22 | 61.0±13.7 | 11:11 | 22 | ||
| UC cases | 35 | 41.8±15.2 | 15:20 | 100 | 5 (Matts 1) | 12.4±1.3 |
| 22 (Matts 2) | 7.0±4.7 | |||||
| 18 (Matts 3) | 6.7±5.1 | |||||
| 55 (Matts 4,5) | 5.5±5.1 |
M, male; F, female; s.d., standard deviation. Normal control mucosa specimens collected at least 5 cm from colon cancer lesions and not associated with IBD were also examined.